Elizabeth M. Wingard

Founder, President & CEO

Ms. Wingard founded Corista with the goal of delivering a platform for physicians that would dramatically improve the delivery of pathology. With more than 25 years experience in business development, sales and marketing, Ms. Wingard has specialized in the introduction of innovative technologies for emerging markets. In previous positions, she was the key driver of growth for companies delivering technologies to Fortune 1000 companies in several industries, including healthcare, telecommunications, banking, and business process management. Ms. Wingard has built revenue streams of over $1B for the business ventures she’s led.

Prior to launching Corista, Ms. Wingard held senior executive positions in sales and business development for a wide range of technology–driven companies, including Op40, Vicorp, IBJ Schroder, Sprint and AT&T.

Ms. Wingard holds a BA and an MA from the University of Southern Mississippi.

Keith Kaplan, MD

Chief Medical Officer

Keith J. Kaplan, MD serves as the company’s Chief Medical Officer.  In this role, Dr. Kaplan contributes to both the development of Corista’s digital pathology platform, and to expanding the market awareness of how Corista’s platforms can materially improve the delivery of pathology while improving patient care.

Dr. Kaplan is board certified in anatomic and clinical pathology. A graduate of Michigan State University, and Northwestern University’s Feinberg School of Medicine, Dr. Kaplan completed his residency training in anatomic and clinical pathology at Walter Reed Army Medical Center, Washington, DC. While at Walter Reed, in conjunction with the Armed Forces Institute of Pathology, Dr. Kaplan founded and directed the Army Telepathology Program. This Program connected 25 hospitals internationally for consultation via telepathology

Dr. Kaplan was also with Mayo Clinic Rochester, Minnesota as an Associate Professor of Pathology of Mayo Medical School. At Carolinas Health Systems in Charlotte, NC, Dr. Kaplan held the Pathology Informatics Chair as CIO of Pathology practice.

Dr. Kaplan currently serves as a member of the College of American Pathologists, American Society of Clinical Pathology and the American Society of Cytopathology as well as the American Pathology Foundation. He is an executive board member of the American Pathology Foundation. Dr. Kaplan is the publisher of tissuepathology.com, the industry’s leading pathology blog, and a contributor to Corista’s blog.

Eric Wirch

Chief Technology Officer & Managing Director

Mr. Wirch joined Corista in 2008 to lead Corista’s platform architecture and product development. Mr. Wirch is focused on creating image-centric solutions for complex workflow and information management issues, emphasizing architecture, scalability, security and system availability. He has over 20 years of experience in the design and implementation of distributed and cloud-based computer systems, primarily for video and imaging systems. Mr. Wirch has designed and deployed solutions for some of the leading companies in video distribution and personalization, including Sequencia Technologies, Gotuit Media (acquired by Digitalsmiths), SeaChange International, The Analytical Sciences Corporation, and Metasignal.

Mr. Wirch represents Corista on the DICOM standards committee. He holds 2 granted patents and several more on file.

Mr. Wirch holds a B.S. in Computer Systems Engineering from Rensselaer Polytechnic Institute.

Robin Weisburger

Manager, Client Support Services

Robin Weisburger, with over 30 years’ experience in anatomic pathology, joined Corista in 2014 as the Manager of Customer Support Services. Most recently the practice manager of anatomic pathology at Dartmouth-Hitchcock Medical Center, Ms. Weisburger has substantial depth in implementing and managing large anatomic pathology laboratory systems.

While at Dartmouth, Robin placed a strong focus on quality systems management, which resulted in a high reduction of errors. She also drove the implementation of an automated block and slide labeling processes and single piece throughput work processes to improve specimen throughput. Since 2011, Ms. Weisburger was responsible for the management and implementation of a digital pathology program at DHMC, which brought the adoption of whole slide images for quality assurance purposes.

Ms. Weisburger has a master’s degree in organization and management from the Antioch University of New England Graduate School, and has completed the Tuck Executive Education Program for Section Chiefs and Practice Managers. She is a certified histotechnologist and a member of the Clinical Laboratory Management Association and the American Society of Clinical Pathologists.

David Spinale

VP, Business Development

David Spinale joined Corista’s leadership team with a focus on helping partners leverage the benefits of a cloud-based whole slide image collaboration platform, across all life science market segments. Mr. Spinale’s unique combination of experience in technology, marketing, business development, clinical operations, and operational leadership have positioned him to implement solutions that will change the face of healthcare delivery.

Mr. Spinale is passionate in his dedication to helping improve access to world-class medical expertise and cutting edge technologies. He has consulted with leading medical centers interested in establishing and expanding telehealth and second review programs. Prior to joining Corista, Mr. Spinale held key roles at Massachusetts General Hospital, Boston Medical Center, lifeIMAGE, and, most recently, as VP of US Operations for Best Doctors.

Mr. Spinale holds a BS in management from Bridgewater State University and an MBA from Suffolk University.

Board & Advisors

Richard Y. Wingard

Founder and Managing Director

Mr. Wingard has 25 years of experience in medical imaging and healthcare technologies. Mr. Wingard has held senior executive positions at Access Radiology Corporation, an early provider of tele-radiology platform services, Tel-Care Inc., Multimedia Medical Systems and Vidimedix Corporation. As the senior executive for Sprint’s Healthcare efforts, Mr. Wingard designed and developed Sprint’s healthcare technology capability, HANDS™, which set the standard for telemedicine and tele-radiology. Prior to joining Sprint, Mr. Wingard directed AT&T’s Healthcare Industry’s Sales and Marketing efforts.

Since 1999, Mr. Wingard has been CEO of Euclid Discoveries, focused on the development of advanced technologies to optimize the delivery of high definition video. Euclid’s proprietary video compression methodology and Intellectual Property provides an improved user experience together with access to high definition video content that has been traditionally restricted by bandwidth.

Mr. Wingard graduated from the University of North Carolina at Charlotte with a BA degree in Psychology.

Charles P. Pace

Founder and Managing Director

Mr. Pace, Consulting Technologist for Euclid Discoveries, has authored nearly 90 worldwide patents in distributed systems, collaborative technologies, computer vision and image understanding. He is an expert technologist having developed innovative technologies in the areas of middleware, analytics, and compression technologies.

Mr. Pace’s experience includes leading mission-critical development efforts for large corporations such as Silknet (Kana), Sprint, and IBM, and building innovative technology platforms for emerging companies, including Euclid Discoveries and Op40.

Mr. Pace graduated from Clarkson University with dual Bachelor of Science degrees in Computer Science and Mathematics.

George Lauro

Board Member

Mr. Lauro has 25 years of experience as a technology entrepreneur, operating executive, and venture capitalist. He was Managing Director/Partner at Wasserstein Perella and was Managing Director at Techfarm Ventures in Silicon Valley. He opened and managed Wasserstein’s tech investing office in Palo Alto, led and syndicated 18 private equity financing rounds and PE control deals, raised over $100M equity financing for portfolio companies and completed M&A transactions exceeding $1B in combined value. He has been a member of the board of directors of 17 public and private companies and has served as Interim CEO.

Earlier in his career, Mr. Lauro was Director of Rapid Commercialization at IBM headquarters where he led a team that launched new businesses based on advanced technology from IBM Watson Research labs including Silicon Germanium (SiGe), Speech Recognition and pervasive computing. George began his career designing inertial guidance systems at MIT/Draper Lab and Astronautics Corp. He holds 23 patents in inertial guidance GPS and RF devices.

Mr. Lauro attended Brown (BSEE), the Wharton School (MBA) and MIT (graduate studies in Aeronautical Engineering).